This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (39)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Erik D. Skarsgard, MD; Joseph M. Connors, MD; Richard E. Robins, MD

Arch Surg. 1991;126(10):1199-1204.

Abstract
• Over a 9-year period ending in May 1990, 27 patients with histologically proved thyroid lymphoma were assessed and treated. There were 24 female and three male patients with a median age of 67 years at the time of diagnosis (age range, 39 to 85 years). The usual presentation was that of a rapidly enlarging neck mass. Incisional biopsy was the diagnostic procedure of choice; however, nine of 27 patients underwent diagnostic partial or total thyroidectomy based on a preoperative impression of thyroid carcinoma. All 27 patients had non-Hodgkin's lymphomas of intermediate (77%) or high (23%) grade. Detailed staging was carried out in 25 patients; seven patients (28%) had disease confined to the thyroid gland (stage I), while 18 (73%) had accompanying disease in cervical lymph nodes or the mediastinum (stage II). Combined multiagent chemotherapy and irradiation was given to 19 of 25 staged patients (76%). Actuarial, overall 5-year survival for all patients was 70% with 48 months being the median follow-up for living patients (follow-up range, 3 to 102 months). Of a number of factors evaluated using log-rank survival tests, only the absence of dysphagia at the time of hospital admission, a primary tumor mass not greater than 10 cm, restriction of disease to the thyroid gland, and the absence of mediastinal lymph node involvement were statistically significant predictors of improved survival. Surgery should usually be restricted to diagnostic biopsy, as there is infrequently a role for resection in the management of thyroid lymphoma, given the effectiveness of combined multiagent chemotherapy and radiotherapy.

(Arch Surg. 1991; 126:1199-1204)

Author Affiliations
From the Departments of Surgery (Drs Skarsgard and Robins) and Medical Oncology (Dr Connors), University of British Columbia, Vancouver.

Footnotes
Accepted for publication June 15, 1991.

Presented at the 62nd Annual Scientific Session of the Pacific Coast Surgical Association, Pebble Beach, Calif, February 19, 1991.

Reprint requests to 600 W 10th Ave, Vancouver, British Columbia, Canada V5Z 4E6 (Dr Connors).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience
Harrington et al.
Br. J. Radiol. 2005;78:405-410.
ABSTRACT | FULL TEXT  

Primary Thyroid Lymphoma Is a Heterogeneous Disease
Thieblemont et al.
J. Clin. Endocrinol. Metab. 2002;87:105-111.
ABSTRACT | FULL TEXT  

A woman with an abnormal mass in the thyroid gland
Postgrad. Med. J. 2001;77:412f-412.
FULL TEXT